Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 4441 AL 4455

Intracellular Aβ and its Pathological Role in Alzheimer's Disease: Lessons from Cellular to Animal Models

Ji L, Zhao X, Lu W, Zhang Q, Hua Z.

Curr Alzheimer Res. 2016;13(6):621-30. doi: 10.2174/1567205013666160322142226.

Gamma Secretase Modulators: New Alzheimer's Drugs on the Horizon?

Bursavich MG, Harrison BA, Blain JF.

J Med Chem. 2016 Aug 25;59(16):7389-409. doi: 10.1021/acs.jmedchem.5b01960. Epub 2016 Apr 5.

Future Therapeutics in Alzheimer's Disease: Development Status of BACE Inhibitors

Evin G.

BioDrugs. 2016 Jun;30(3):173-94. doi: 10.1007/s40259-016-0168-3.

[Research progress in pharmacological effects of Uncaria Hook on Alzheimer disease models]

Liu L, Zhao YH, Zeng CQ, Zeng Y.

Yao Xue Xue Bao. 2016 Apr;51(4):536-42.

Substance P and Alzheimer's Disease: Emerging Novel Roles

Severini C, Petrella C, Calissano P.

Curr Alzheimer Res. 2016;13(9):964-72. doi: 10.2174/1567205013666160401114039.

Ethical Considerations for the Use of Next-Generation Alzheimer Drugs in Symptomatic and At-Risk Patients

Gauthier S, Rosa-Neto P, Kass JS.

Continuum (Minneap Minn). 2016 Apr;22(2 Dementia):615-8. doi: 10.1212/CON.0000000000000306.

Alzheimer's Disease Mechanisms and Emerging Roads to Novel Therapeutics

Sala Frigerio C, De Strooper B.

Annu Rev Neurosci. 2016 Jul 8;39:57-79. doi: 10.1146/annurev-neuro-070815-014015. Epub 2016 Apr 4.

Rhodiola rosea L. and Alzheimer's Disease: From Farm to Pharmacy

Nabavi SF, Braidy N, Orhan IE, Badiee A, Daglia M, Nabavi SM.

Phytother Res. 2016 Apr;30(4):532-9. doi: 10.1002/ptr.5569. Epub 2016 Jan 11.

sFRP-mediated Wnt sequestration as a potential therapeutic target for Alzheimer's disease

Warrier S, Marimuthu R, Sekhar S, Bhuvanalakshmi G, Arfuso F, Das AK, Bhonde R, Martins R, Dharmarajan A.

Int J Biochem Cell Biol. 2016 Jun;75:104-11. doi: 10.1016/j.biocel.2016.04.002. Epub 2016 Apr 7.

Navigating the Chemical Space of Multitarget-Directed Ligands: From Hybrids to Fragments in Alzheimer's Disease

Prati F, Cavalli A, Bolognesi ML.

Molecules. 2016 Apr 8;21(4):466. doi: 10.3390/molecules21040466.

DYRK1A inhibition as potential treatment for Alzheimer's disease

Stotani S, Giordanetto F, Medda F.

Future Med Chem. 2016 Apr;8(6):681-96. doi: 10.4155/fmc-2016-0013. Epub 2016 Apr 13.

Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics

Rosini M, Simoni E, Caporaso R, Minarini A.

Future Med Chem. 2016 Apr;8(6):697-711. doi: 10.4155/fmc-2016-0003. Epub 2016 Apr 15.

Progress in drug development for Alzheimer's disease: An overview in relation to mitochondrial energy metabolism

Hroudová J, Singh N, Fišar Z, Ghosh KK.

Eur J Med Chem. 2016 Oct 4;121:774-784. doi: 10.1016/j.ejmech.2016.03.084. Epub 2016 Mar 30.

Targeting microglia for the treatment of Alzheimer's Disease

Wes PD, Sayed FA, Bard F, Gan L.

Glia. 2016 Oct;64(10):1710-32. doi: 10.1002/glia.22988. Epub 2016 Apr 21.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias